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Abstract
Background: Dietary long-chain polyunsaturated fatty acids (LC-PUFA) are of crucial importance for the
development of neural tissues. The aim of this study was to evaluate the impact of a dietary supplementation in
n-3 fatty acids in female rats during gestation and lactation on fatty acid pattern in brain glial cells
phosphatidylethanolamine (PE) and phosphatidylserine (PS) in the neonates.
Methods: Sprague-Dawley rats were fed during the whole gestation and lactation period with a diet containing
either docosahexaenoic acid (DHA, 0.55%) and eicosapentaenoic acid (EPA, 0.75% of total fatty acids) or a-linolenic
acid (ALA, 2.90%). At two weeks of age, gastric content and brain glial cell PE and PS of rat neonates were
analyzed for their fatty acid and dimethylacetal (DMA) profile. Data were analyzed by bivariate and multivariate
statistics.
Results: In the neonates from the group fed with n-3 LC-PUFA, the DHA level in gastric content (+65%, P <
0.0001) and brain glial cell PE (+18%, P = 0.0001) and PS (+15%, P = 0.0009) were significantly increased compared
to the ALA group. The filtered correlation analysis (P < 0.05) underlined that levels of dihomo-g-linolenic acid
(DGLA), DHA and n-3 docosapentaenoic acid (DPA) were negatively correlated with arachidonic acid (ARA) and n-6
DPA in PE of brain glial cells. No significant correlation between n-3 and n-6 LC-PUFA were found in the PS
dataset. DMA level in PE was negatively correlated with n-6 DPA. DMA were found to occur in brain glial cell PS
fraction; in this class DMA level was correlated negatively with DHA and positively with ARA.
Conclusion: The present study confirms that early supplementation of maternal diet with n-3 fatty acids supplied
as LC-PUFA is more efficient in increasing n-3 in brain glial cell PE and PS in the neonate than ALA. Negative
correlation between n-6 DPA, a conventional marker of DHA deficiency, and DMA in PE suggests n-6 DPA that
potentially be considered as a marker of tissue ethanolamine plasmalogen status. The combination of multivariate
and bivariate statistics allowed to underline that the accretion pattern of n-3 LC-PUFA in PE and PS differ.
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Nutrient supply is of crucial importance in the matura-
tion and functional development of the central nervous
system [1]. Long-chain polyunsaturated fatty acids (LC-
PUFA) such as arachidonic acid (ARA, C20:4n-6) and
docosahexaenoic acid (DHA, C22:6n-3) are major con-
stituents of membrane phospholipids in the brain and
the retina [2]. It has been shown that the level of DHA
in retinal phospholipids has a strong impact on visual
transduction processes and subsequently to visual func-
tion assessed by electroretinography [3,4]. Beside their
structural implications, biologically active derivatives of
LC-PUFA such as neuroprotectins and resolvins, are
involved in neuroprotection, signalling and maintaining
or lowering the inflammatory response [5-7].
ARA and DHA can be synthesized from dietary essen-
tial fatty acids: linoleic (18:2n-6, LA) and a-linolenic
(ALA, C18:3n-3) acids, respectively, through a series of
elongation and desaturation steps catalyzed by the same
key enzymes, namely Δ6- and Δ5-desaturases [2]. There-
fore, the level of LA and ALA in the diet is very impor-
tant to ensure adequate deposition of LC-PUFA in
membrane phospholipids in the neonate [2,8-10]. How-
ever, it has been demonstrated in many neonate animal
models that the rate of conversion of ALA to DHA is
not appropriate to sustain optimal DHA accretion in the
brain and the retina just after birth [11-13]. Neverthe-
less, the DHA supply is a key factor for the ocular and
cerebral development steps that take place during the
last trimester of pregnancy in humans [14]. It has been
demonstrated that the maternal conversion rate of ALA
to DHA is not sufficient to fulfil the needs of the foetus
[14]. Therefore, it is currently recommended to con-
sume LC-PUFA rich foods during pregnancy and lacta-
tion in order to deliver the optimal level of DHA to the
foetus [14]. It has been demonstrated that maternal sup-
plementation with n-3 LC-PUFAs might positively influ-
ence cognitive performance in infants [15] but the
number of conclusive reports in this area is limited.
In a recent study, Bowen and Clandinin [10] clearly
demonstrated that dietary supply of DHA is more effi-
cient than ALA to increase the DHA level in brain (cer-
ebrum plus cerebellum) glial cell phospholipids in rat
neonates during lactation [10]. Glial cells are important
support to neuronal cells and especially for neurotrans-
mission, neuroprotection, energy maintenance and sup-
ply of key elements [1]. It has been shown that glial
cells are able to convert fatty acids and synthesize LC-
PUFAs while it is not the case for neuronal cells [16].
The present study has been carried out with the same
experimental design except that the nutritional interven-
tion started earlier, i.e.d u r i n gg e s t a t i o n ,a n dw a sm a i n -
tained throughout lactation. This design allows to study
the effect of the maternal nutrition along all the stages
of neurodevelopment that started in utero and are
almost completed at weaning in rat [1]. Maternal milk
compositions have been assessed by analyzing gastric
content of neonates two weeks after birth. Analysing the
fatty acid composition of the gastric content gives
insight on the maternal milk composition. The fatty acid
composition of phosphatidylethanolamine (PE) and
phosphatidylserine (PS) brain glial cells has been
assessed in 14 days rat neonates. A combination of mul-
tivariate and bivariate statistics has been used to better
exemplify how n-3 fatty acids, supplied in the maternal
diet as precursor (ALA) or LC-PUFA (EPA and DHA),
impact fatty acid pattern in brain glial cell PE and PS,
the two main classes of phospholipids rich in LC-PUFA.
Materials and methods
Animals and experimental design
The protocol was conducted following the Guidelines for
t h eC a r ea n dU s eo fE x p e r i m e n t a lA n i m a l sand
approved by the local ethical committee. Sprague Daw-
ley rats (11 weeks of age) were mated for a period of 10
days (1 male + 1 female per cage) at INRA (Animal
Breeding House, INRA Research Center, Dijon, France)
under controlled conditions for light (lights on, 7:00
AM-7:00 PM), temperature (22 ± 1°C) and hygrometry
(55-60%). Water and food were supplied ad libitum to
the animals from the first day of the mating period until
the end of the suckling period. At day 1 after parturi-
tion, the number of pups was adjusted to 10 neonates
per litter. Mortality of the pups was recorded daily after
parturition until the end of the follow-up. Pups were
weighed once a week.
Dietary fatty acid supplementation
The composition of the diets and the n-3 fatty acid con-
tent of dietary fat is provided in Table 1. The relative
distribution of fatty acid classes was similar to that
Table 1 Composition of the experimental diets (in g per
kg of diet)
Nutrient (in g/
kg diet)
ALA n-3 LC-PUFA Energy %
Lipid blend 200.00 200.00 39.9
Casein 270.00 270.00 23.9
Starch 200.00 200.00 17.7
Sucrose 207.65 207.65 18.4
Non nutritive
fiber
50.00 50.00 0.0
Vitamins (mix) 10.00 10.00 0.0
Minerals (mix) 50.85 50.85 0.0
L-methionin 2.50 2.50 0.0
Choline 2.75 2.75 0.0
Inositol 6.25 6.25 0.0
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ALA lipid blend contained rapeseed oil (27.1%), cocoa
butter (23.4%), coconut oil (18.7%), high-oleic sunflower
oil (15.9%), and sunflower oil (14.8%). The n-3 LC-
PUFA lipid blend was composed of rapeseed oil (21.6%),
cocoa butter (21.6%), coconut oil (19.2%), high-oleic
sunflower oil (17.4%), sunflower oil (15.0%) and fish oil
(5.2%).
Tissue collection
Male pups were euthanized at day 14 after birth (n = 24
in each group). Brains (cerebrum plus cerebellum) were
excised and placed in ice-cold 0.32 M sucrose as pre-
viously described [10,17]. Six brains from pups at day 14
were pooled together for glial cell separation. A total of
4 pools were prepared and used as a starting material
for glial cell isolation. The gastric content of pups sacri-
ficed at day 14 after birth was removed and stored at
-80°C until further analysis.
Isolation of brain glial cells from brain samples
Glial cells were purified from the whole brain (cerebrum
plus cerebellum) by centrifugation as described in the lit-
erature [17]. Briefly, pooled brains were homogenized in
7.5% (w/v) polyvinylpyrrolidone and 10 mM CaCl2 at pH
4.7 and 25°C. The homogenate was layered on a two-step
sucrose gradient of 1.0 and 1.75 M. After centrifugation
at 41,000 g for 30 min at 4°C, glial cells were isolated
from the interface of the 1.0 and 1.75 M sucrose layers.
Lipid Extraction
Lipids were extracted from brain glial cells and gastric
content according to the Folch procedure [18].
Phospholipid separation by high-performance liquid
chromatography (HPLC)
Phospholipids from brain glial cell lipid extracts were
separated by preparative HPLC using a Lichrosorb Si60
(5 μm, Merck) fitted with a light-scattering detector as
described in the literature [19]. Fractions containing PS
a n dP Ew e r ec o l l e c t e da n ds t o r e da t- 8 0 ° Cu n d e ri n e r t
nitrogen-conditions before fatty acid analysis.
Fatty acid analysis by gas-liquid chromatography (GLC)
Fatty acid methyl esters (FAME) were prepared from
gastric contents following the methods of Glass [20]
while for the experimental diets and glial cells, the
method described by Morrison and Smith [21] was
used. FAME samples were analyzed by gas-liquid chro-
matography using a fused silica capillary column (CP-Sil
88, 100 m × 0.25 mm id, 0.25 μm film thickness, Varian,
Les Ulis, France) operating under conditions described
elsewhere [22,23].
Statistical analyses
Bivariate statistical analysis
Fatty acid profile of pup’s gastric content, PE and PS
brain glial cells were analyzed by ANOVA procedure,
followed by post-hoc Dunnett’s test, using the SAS
software (SAS Institute, Cary, USA). Differences were
considered as significant at P < 0.05.
Principal Components Analysis (PCA)
PCA was used to analyze the fatty acid profile of PE and
PS purified from brain glial cell samples. Data pretreat-
ment, correlation analysis and Principal Component
Analysis were done on Matlab™ 7.5 (The Mathworks,
Inc., MA, USA). In-house written routines were used for
data import and visualization, whilst preprocessing, cor-
relation analysis and PCA modeling were done using
the PLS-Toolbox v 5.22 (Eigenvector Research Inc., WA,
USA).
Results
Animal data
Supplementation with n-3 LC-PUFA during gestation did
not modify any characteristics of the newborn rats com-
pared to the control group in terms of number of pups
per litter, weight and growth of the rats during the first
two weeks of age of the pups (Table 2). No significant
differences were observed between both groups of ani-
mals, neither at the time of parturition nor at weaning.
Fatty acid composition of the experimental diets
In the present study, lipid represented about 40% of the
energy provided by the experimental diets (Table 1).
This level reflects the energy coming from lipids in typi-
cal US diet and was previously used in similar studies
Table 2 Data on reproduction efficiency and weight of
animals at birth and during the first two weeks of age.
Parameters Experimental group
ALA n-3 LC-PUFA
Mating efficiency
(pregnant females/total
mated females)
16/18 16/18
Parturition time after
starting to mate (days)
24 ± 1 22 ± 1
Total number of newborn
male rats (from 16 litters)
105 110
Total number of newborn
female rats (from 16
litters)
100 118
Number of newborn rats
per litter
12.8 ± 4.5 14.3 ± 3.0
Mean weight of the
newborn rat (g)
7.7 ± 1.7 7.1 ± 0.7
Mean weight of the rat at
birth after adjusting to 10
rats per litter (g)
7.7 ± 1.5 7.2 ± 0.6
Mortality during the first
days of life (n)
1 at 7 days 3 at 7 days
Weight of the rat at day
14 (g)
46.3 ± 3.3 46.0 ±4.3
Brain weight at day 14 (g) 1.37 ± 0.13 1.34 ± 0.09
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of the experimental diets is provided in Table 3. The
ALA diet does not contain any n-3 LC-PUFA while the
lipid fraction of the n-3 LC-PUFA experimental diet
contains EPA and DHA (0.75 and 0.55% of total fatty
acids, respectively). The level of saturated, monounsatu-
rated and polyunsaturated fatty acids were balanced in
both experimental diets to c.a. 37-38, 42-43 and 20% of
total fatty acids, respectively. The n-6 to n-3 fatty acid
ratios were 8 and 5 for the ALA and n-3 LC-PUFA
experimental diets, respectively (Table 3).
Fatty acid composition of the gastric content of rat pups
at day 14
The analysis of the fatty acid composition of gastric
content of rat pups is commonly used to assess the
fatty acid composition of the maternal milk [10]. The
detailed fatty acid distribution in the different groups
corresponding to neonates from mother fed with the
ALA or n-3 LC-PUFA diets is provided in Table 4.
Statistical analysis revealed that rat pups from ALA
group received more medium chain fatty acids C8:0
(+23%, P = 0.002) and C10:0 (+40%, P = 0.001), palmi-
tic (C16:0) acid (+11%, P = 0.001), palmitoleic (C16:1
n-9) acid (+46%, P = 0.006), C22:4 n-6 (n-6 DTA,
+125%, P = 0.001) and C22:5 n-6 (n-6 DPA, +200%, P
=0 . 0 0 3 )f r o mm a t e r n a lm i l kc o m p a r e dt on - 3L C -
PUFA group (Table 4). Conversely and as expected,
the gastric content of the pups from the n-3 LC-PUFA
group received more EPA (+83%, P = 0.0003), C22:5
n-3 (n-3 DPA, +68%, P < 0.0001) and DHA (+65%, P <
0.0001) than pups from the ALA group. In addition,
the levels of stearic (C18:0) acid (+16%, P = 0.002) and
ALA (+24%, P = 0.007) were significantly higher in the
n-3 LC-PUFA group.
Fatty acid profile of brain glial cells PE and PS at day 14:
bivariate statistics
The fatty acid composition of the PE classes (left columns
in Table 5) was characterized by a high level of ARA and
DHA that represented together more than 40% of total
fatty acids. The level of ARA, and n-6 DPA found in rat
neonates from dams fed with n-3 LC-PUFA was lower
compared to the ALA group (P < 0.001). The most impor-
tant variation observed was the increase of DHA (+18%, P
= 0.0001) and dihomo-g-linolenic acid (C20:3 n-6, DGLA)
(+22%, P = 0.0018) in the n-3 LC-PUFA group. The level
Table 3 Fatty acid composition of the experimental diets.
ALA n-3 LC-PUFA
C8:0 1.50 1.55
C10:0 1.27 1.33
C12:0 8.70 9.14
C14:0 3.26 3.72
C16:0 10.63 10.96
C17:0 0.08 0.11
C18:0 10.64 10.13
C20:0 0.54 0.51
C22:0 0.37 0.37
C24:0 0.13 0.13
C16:1 0.16 0.54
C18:1n-9 40.94 39.27
Other C18:1 1.73 1.69
C20:1 0.44 0.42
C18:2n-6 17.38 16.77
C18:3n-3 2.22 1.83
C20:5n-3 - 0.75
C22:5n-3 - 0.08
C22:6n-3 - 0.55
Results of duplicate analysis are expressed as g/100 g total fatty acids.
Table 4 Fatty acid composition of the gastric content of
rat pups at 14 days of age (g/100 g total fatty acids).
ALA n-3 LC-PUFA
Mean ± SD P values
C6:0 0.20 ± 0.03 0.22 ± 0.02 n.s.
C8:0 4.17 ± 0.25 3.38 ± 0.17 0.002
C10:0 10.44 ± 0.79 7.43 ± 0.65 0.001
C12:0 9.41 ± 0.59 9.93 ± 0.32 n.s.
C14:0 6.75 ± 0.50 6.40 ± 0.41 n.s.
C15:0 0.11 ± 0.01 0.12 ± 0.02 n.s.
C16:0 12.93 ± 0.14 11.65 ± 0.43 0.001
C17:0 0.12 ± 0.01 0.14 ± 0.01 0.031
C18:0 5.01 ± 0.19 5.99 ± 0.35 0.002
C20:0 0.14 ± 0.04 0.19 ± 0.02 n.s.
C22:0 0.07 ± 0.02 0.03 ± 0.01 0.017
C24:0 0.04 ± 0.01 0.06 ± 0.02 n.s.
C14:1 0.02 ± 0.00 0.02 ± 0.00 n.s.
C16:1 0.98 ± 0.13 0.67 ± 0.08 0.006
C17:1 0.06 ± 0.00 0.08 ± 0.01 0.050
C18:1n-9 30.40 ± 1.38 32.97 ± 0.41 0.012
Other C18:1 1.82 ± 0.44 2.82 ± 0.11 0.005
C20:1 0.58 ± 0.12 0.44 ± 0.04 n.s.
C22:1 0.04 ± 0.01 0.04 ± 0.00 n.s.
C24:1 0.04 ± 0.04 0.03 ± 0.00 n.s.
C18:2n-6 13.65 ± 0.53 13.29 ± 0.21 n.s.
C20:2n-6 0.33 ± 0.04 0.28 ± 0.02 n.s.
C20:4n-6 0.80 ± 0.15 0.51 ± 0.07 0.011
C22:2n-6 0.04 ± 0.01 0.06 ± 0.01 0.013
C22:4n-6 0.18 ± 0.02 0.08 ± 0.02 0.001
C22:5n-6 0.09 ± 0.02 0.03 ± 0.01 0.003
C18:3n-3 0.99 ± 0.13 1.31 ± 0.09 0.008
C20:3n-3 0.04 ± 0.01 0.04 ± 0.01 n.s.
C20:5n-3 0.09 ± 0.01 0.52 ± 0.11 0.0003
C22:5n-3 0.11 ± 0.02 0.34 ± 0.03 < 0.0001
C22:6n-3 0.33 ± 0.04 0.93 ± 0.08 < 0.0001
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vinyl-ether residues in PE plasmalogens was higher in rat
neonate from the n-3 LC-PUFA group compared to the
other group of animals (+12%, P = 0.0155).
The fatty acid composition of the PS classes (right col-
umns in Table 5) was characterized by high levels of ARA,
n-6 DTA and DHA. The level of DHA was significantly
increased in the n-3 LC-PUFA group (+15%, P = 0.0009)
while the level of n-6 DPA was much lower in the LC-
PUFA group (-47%, P < 0.0001) compared to the ALA
group. The levels of other n-6 LC-PUFA were not signifi-
cantly different between groups but the n-3 to n-6 ratio
was significantly higher (1.84 ± 0.11) in rat neonates from
dams fed with n-3 LC-PUFA compared to the ALA group
(1.37 ± 0.06, P = 0.0004, data not shown).
Fatty acid profile of brain glial cell PE and PS at day 14:
PCA analyses
The fatty acid composition of the PE was analyzed by
PCA. Data were arranged in a set of rows (samples) and
columns (variables). Variables contained quantitative
values of the different fatty acids (data expressed as g
per 100 g of fatty acid) including DMA (sum of indivi-
dual DMA). Afterwards, data were arranged in a second
time, for both n-3 LC-PUFA and ALA group samples,
to help in the determination of the differences between
the two groups. The data set obtained was analyzed by
means of PCA. Data were pre-processed, each variable
was centred and scaled to unit standard deviation in
order to harmonize the contribution of all the variables.
The optimal number of parameters of the model (Prin-
cipal Components) was obtained after internal cross-
validation. In these conditions, a one principal
component model was determined to be optimal. This
component explained a 41.77% of total variance in the
data (Figure 1A). The second principal component
explained intra-class variation and accounted for 20.86%
of total variance (Figure 1A).
The analysis of the PCA scores of the first principal
c o m p o n e n t1( P C 1 )s h o w e dac l e a rd i s c r i m i n a t i o n
between both groups of samples issued from n-3 LC-
PUFA and ALA groups (Figure 1A). To determine the
contribution of the variables to this model, PC1 loadings
were analyzed (Table 6). This analysis highlighted the
major contribution of C14:0, C20:0, C24:0, C18:2, C20:3
n-6, C22:5 n-3, C22:6 n-3, and DMA to the profile
representative of n-3 LC-PUFA class. On the contrary,
compounds like C18:0, C18:1, C20:4 n-6, and C22:5 n-6
were relevant for the characterization of the ALA group.
Following the same internal validation procedure as
for PE data, PCA on PS data showed a model with two
principal components, thus reflecting some more com-
plex structure. As shown in Figure 1B, discrimination
was also possible along the PC1 (37.94% of total var-
iance), but now with some relevant information
explained by PC2 (28.63% of total variance). In this case,
the analysis of the influence of the variables on the
model was done by plotting the loadings of the first two
components (Table 6). Accordingly, the n-3 LC-PUFA
group was mainly characterized by its contents in C18:0,
C16:1, C18:2 n-6, C18:3 n-3 and C22:6 n-3. Alterna-
tively, fatty acids such as C14:0, C16:0, C20.0, C20:1,
C20:5 n-3, C22:0, C20:4 n-6, C22:5 n-6, C22:5 n-3 and
DMA explained the variability observed in the ALA
group.
Table 5 Effect of maternal dietary -linolenic acid (ALA) compared to n-3 LC-PUFA (EPA+DHA) on the polyunsaturated
fatty acid and DMA composition of phosphatidylethanolamine (PE) and phosphatidylserine (PS) in brain glial cells of
pups (g/100 g total fatty acids).
Phosphatidylethanolamine (PE) Phosphaptidylserine (PS)
Experimental group Experimental group
ALA n-3 LC-PUFA ALA n-3 LC-PUFA
Mean ± SD P values Mean ± SD P values
C18:2n-6 1.04 ± 0.12 1.17 ± 0.07 n.s. 0.46 ± 0.05 0.55 ± 0.18 n.s.
C20:2n-6 0.35 ± 0.03 0.32 ± 0.10 n.s. 0.32 ± 0.03 0.32 ± 0.08 n.s.
C20:3n-6 0.73 ± 0.01 0.93 ± 0.02 0.0018 0.77 ± 0.11 0.77 ± 0.09 n.s.
C20:4n-6 20.16 ± 0.84 17.34 ± 0.45 < 0.0001 7.93 ± 0.32 7.38 ± 0.19 n.s.
C22:4n-6 7.17 ± 0.49 6.99 ± 0.27 n.s. 6.53 ± 0.30 5.94 ± 0.71 n.s.
C22:5n-6 2.71 ± 0.21 1.64 ± 0.07 0.0003 4.07 ± 0.48 2.14 ± 0.29 < 0.0001
C18:3n-3 0.11 ± 0.07 0.12 ± 0.05 n.s. 0.16 ± 0.02 0.19 ± 0.03 n.s.
C20:5n-3 0.12 ± 0.07 0.11 ± 0.05 n.s. 0.18 ± 0.03 0.11 ± 0.05 n.s.
C22:5n-3 0.65 ± 0.02 0.80 ± 0.06 n.s. 1.07 ± 0.10 0.93 ± 0.16 n.s.
C22:6n-3 22.89 ± 0.60 27.83 ± 0.72 0.0001 26.15 ± 0.73 30.12 ± 2.27 0.0009
DMA 8.29 ± 0.34 9.40 ± 0.79 0.0155 2.18 ± 0.49 1.57 ± 0.52 n.s.
Data obtained from four pools of 6 brains excised from rat pups at 2 weeks of age.
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phosphatidylserine (PS) fatty acid profiles.
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Correlation analyses
Correlation analysis was applied to PE and PS data to
identify possible correlations between fatty acids from
the brain glial cell data set. To discard non-significant
associations, filtering based on significance at P < 0.05
was applied to the correlation coefficients (Figure 2A).
From the filtered correlation matrix, it appears that in
the PE data set, DHA (-0.9404), n-3 DPA (-0.8385) but
also DGLA (-0.9366) are negatively correlated with
ARA. DGLA is positively correlated with n-3 DPA
(0.8937) and DHA (0.9618). As expected, n-3 DPA and
DHA are also positively correlated by each others
(0.8909). ARA is negatively correlated with its precursor
C18:2 n-6 (-0.7602) and positively correlated with its
elongation/desaturation product n-6 DPA, (0.9394).
From this analysis, it is also possible to identify positive
correlation between EPA and its precursor ALA
(0.8722) but also with C20:2 n-6 (0.7392). This analysis
allowed to identify significant negative correlations
between the level of DMA (plasmalogen derivative) and
n-6 DPA (-0.783) and C18:0 (-0.718).
PS fatty acid profile data set was also processed and
data were filtered based on the significance level at P <
0.05. The analysis (Figure 2B) shows less correlation and
the significant ones were different when compared to
the PE data set. It was possible to determine that ARA
and DHA provide significant correlations (0.7218 and
-0.7422, respectively) with serine derived plasmalogen
DMA. In addition, EPA was found to be positively cor-
related with n-3 DPA and negatively correlated with
DHA (0.9372, -0.8364).
Discussion
In the present study, the effect of ALA supplementation
has been not studied using a control group depleted in n-3
fatty acids. The effect of various amount of ALA on fatty
acid distribution in rat neonates had been already studied
and it has been clearly demonstrated that ALA supple-
mentation does not significantly modify the level of the
main n-3 LC-PUFA in brain glial cell PS and PE [10]. The
main objective of the study was to compare the effect of
ALA and n-3 LC-PUFA supplementation on the fatty acid
composition of brain glial cells PS and PE with emphasis
on n-3 LC-PUFAs such as DHA and DMAs.
It has been recently shown that DHA may act as
synaptic regulator in astrocytes [24] and therefore its
level might influence important function such as neuro-
transmission which is a key function of glial cells
[24,10]. DHA accretion in PE and PS brain glial cells is
Table 6 PCA Loading values for models on PE (41.77% total X-Variance) and PS (37.94% total X-Variance, PC1/28.63%
total X-Variance, PC2) data.
Fatty acids PE Data PS Data
X-Loading (PC1) Group X-Loading (PC1) X-Loading (PC2) Group
C14:0 0.18 n-3 LC-PUFA 0.28 0.10 ALA
C16:0 -0.16 ALA 0.16 0.09 ALA
C17:0 0.10 n-3 LC-PUFA 0.23 0.25
C18:0 -0.32 ALA -0.14 0.26 n-3 LC-PUFA
C20:0 0.28 n-3 LC-PUFA 0.26 0.02 ALA
C22:0 0.06 n-3 LC-PUFA 0.19 -0.22
C24:0 0.24 n-3 LC-PUFA 0.29 0.10
C16:1 0.06 n-3 LC-PUFA 0.04 0.34 n-3 LC-PUFA
C18:1 -0.24 ALA 0.18 0.23
C20:1 -0.04 ALA 0.32 -0.15 ALA
C18:2 n-6 0.21 n-3 LC-PUFA 0.00 0.31 n-3 LC-PUFA
C20:2 n-6 -0.03 ALA 0.17 0.33
C20:3 n-6 0.33 n-3 LC-PUFA 0.07 0.11
C20:4 n-6 -0.32 ALA 0.17 -0.26 ALA
C22:4 n-6 -0.07 ALA 0.04 -0.36
C22:5n-6 -0.33 ALA 0.27 -0.24 ALA
C18:3 n-3 0.02 n-3 LC-PUFA -0.10 0.34 n-3 LC-PUFA
C20:5 n-3 -0.03 ALA 0.32 0.04 ALA
C22:5n-3 0.31 n-3 LC-PUFA 0.29 0.11 ALA
C22:6 n-3 0.33 n-3 LC-PUFA -0.32 -0.02 n-3 LC-PUFA
DMA 0.24 n-3 LC-PUFA 0.25 -0.08 ALA
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The metabolism of PE and PS in neural cells has been
extensively investigated over the past few years and it
has been shown that PE can be converted into PS (and
vice et versa) and that DHA containing PS species are
involved in neuronal survival and differentiation [see
reference for an extensive review [25].
As described in the literature [10], the analysis of the
gastric content of pups sacrificed at day 14 revealed that
mother milk derived from dams fed with n-3 LC-PUFA
contain higher level of n-3 fatty acids (ALA, EPA, n-3
DPA and DHA) than milk deriving from dams fed only
ALA (Table 4). The level of n-3 fatty acids was two
times higher in the gastric content of rat pups in the n-
3L C - P U F Ag r o u pt h a ni nt h eA L Ag r o u p .I nt h eA L A
group, the n-3 LC-PUFA in the gastric content derived
from the maternal conversion of ALA and in some
extend may originate from n-3 LC-PUFA stores in
maternal adipose tissues. However, in the n-3 LC-PUFA
group, DHA and EPA mainly derived from the maternal
diet. Therefore, the ALA supplied through the maternal
diet was not extensively metabolized which results in a
higher level of ALA in the gastric content compared to
the ALA group (Table 4). The transfer of n-3 fatty acids
and especially DHA from the dams to the pups was
higher in the n-3 LC-PUFA group and can explain the
higher DHA level observed in brain glial cell PE and PS
(Table 5).
The PCA analyses performed on the PE and PS fatty
acid profiles clearly demonstrated how the lipid compo-
sition of maternal diet and especially the supply with
different n-3 fatty acids might impact the FA composi-
tion of the brain glial cell PE and PS of rat neonates
(Figure 1). The effect of supplementation with DHA on
the balance between n-6 and n-3 fatty acid and espe-
cially the level of ARA and n-6 DPA in various tissues is
well documented [2,10,26]. The present approach com-
bining bivariate and multivariate statistics allowed to
identify discrete correlations between the different PE
and PS residues (Figure 2). We observed numerous cor-
relations between the n-3 and n-6 LC-PUFA in the PE
data set. The PE correlation matrix clearly demonstrated
that n-3 LC-PUFA are negatively correlated with ARA
and its elongation/desaturation product n-6 DPA but
positively correlated to DGLA as previously reported in
the serum and the retina [27,28]. ARA and EPA are
formed from DGLA and 20:4 n-3, respectively through a
Δ5 desaturase activity. It is well known EPA inhibits Δ5
enzyme activity which is necessary to convert DGLA
into ARA [27,28]. It might explain why n-6 PUFA are
favored whereas those formed downstream are limited
when EPA is provided by the diet. This analysis also
confirmed that n-6 DPA and DHA are negatively corre-
lated (-0.9476); which confirms existing literature
showing that n-6 DPA is a good marker of DHA defi-
ciency [10,25,28,29]. Interestingly, the correlation analy-
sis revealed that the level of plasmalogen residues
(plasmenylethanolamine DMA) was negatively correlated
with n-6 LC-PUFA (Figure 2), but not significantly cor-
related with any n-3 LC-PUFA. DMA represent about
8-9% of total PE residues (Table 5). It has been shown
that deficiency of n-3 fatty acids in the diet may result
in plasmalogen deficiency associated with abnormal sig-
nal transduction process in neural membranes [30].
Conversely, dietary supplementation with DHA to Zell-
weger patients whose tissues are strongly deficient in
DHA [31] increased plasmalogen levels in erythrocytes
[ 3 2 ] .T h ep r e s e n to b s e r v a t i o nm i g h ti n d i c a t et h a tn - 6
DPA level can potentially be used as an indicator of
plasmenylethanolamine (PE plasmalogen) deficiency in
brain glial cells.
The results of the analysis of the PS correlation matrix
showed no correlation between n-6 and n-3 LC-PUFA
(see the blank squared areas in the correlation matrix).
EPA was positively correlated with its metabolite n-3
DPA but not with the end product DHA. Fatty acids
up-taken from the general circulation or de novo synthe-
sized were incorporated in PE but as well in phosphati-
dylcholine (PC) by deacylation/reacylation reaction [25].
However, PS are selectively produced from PE by serine
exchange-catalyzed reaction [25].
The only noticeable correlation observed in the PS
dataset is related to DMA level that are negatively corre-
lated with DHA (-0.7422) and positively with ARA
(0.7218). This might indicate that serine plasmalogen
might contain significant levels of ARA in the Sn-2 posi-
tion of the phosphatidylglycerol backbone. DMA repre-
sent 1.5 to 2.2% of the residue found to be linked to PS
in brain glial cells (Table 5). Few reports mention the
occurrence of serine plasmalogen in human erythrocytes
[33,34] but, to our knowledge, serine plasmalogens have
never been characterized in neural cells. It appears from
these analyses that ethanolamine and serine plasmalogen
might differ in their compositions and subsequently, one
can hypothesize that they might differ in their metabo-
lism and function.
The different phases of brain development occur dif-
ferently in rats and humans. At birth the first two steps
of early gliogenesis and macroneurogenesis are complete
in rats whereas they happen during the first six months
of gestation in humans [1]. It has been demonstrated in
newborn rats that the DHA requirements at 2 weeks of
age are very important [10]. This period corresponds to
the microneurogenesis, late gliogenesis and microneuro-
genesis. At this stage, the level of DHA accretion is high
in whole brain glial cell phospholipids as well as in iso-
lated PE and PS [10]. It has been clearly shown that
dietary DHA is more efficient than dietary ALA to
Destaillats et al. Nutrition Metabolism 2010, 7:2
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supplementation of maternal diet with n-3 LC-PUFA
affects the fatty acid composition of PE and PS brain
glial cells during their initial developmental steps.
Conclusion
The results of the present study confirm that the lipid
composition of the maternal diet during gestation and
lactation have a significant impact on the fatty acid
composition of brain glial cell PE and PS in the neo-
nates. The combination of multivariate and bivariate sta-
tistics allowed to better understand how n-3 fatty acids
supplied in the maternal diet as precursor (ALA) or LC-
PUFA (EPA and DHA) influence the fatty acid profile of
brain glial cell PE and PS in the neonates. In PE, n-3
and n-6 LC-PUFA are correlated, consistently with lit-
erature but the correlation analysis of PS residue profile
did not show any correlation showing their distinct
metabolic pathways. Negative correlation between n-6
DPA, a conventional marker of DHA deficiency, and
DMA in PE showed that potentially n-6 DPA can be
considered as a potent marker of ethanolamine plasma-
logen. In addition, we observed in this study that serine
plasmalogen occur in brain glial cells of rat neonates
and that the level of DMA residue is negatively corre-
lated with DHA but positively correlated with ARA.
This might indicate that serine plasmalogen might con-
tain significant level of ARA in the Sn-2 position of the
phosphatidylglycerol backbone.
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